Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva Analysts Stick to ‘Buy’ Ratings as Stock Repays Love With 41% Decline
Teva Analysts Stick to ‘Buy’ Ratings as Stock Repays Love With 41% Decline
Teva Analysts Stick to ‘Buy’ Ratings as Stock Repays Love With 41% Decline
Submitted by
admin
on August 11, 2011 - 2:02pm
Source:
Bloomberg
News Tags:
Teva Pharmaceuticals
analysts
Headline:
Teva Analysts Stick to ‘Buy’ Ratings as Stock Repays Love With 41% Decline
Do Not Allow Advertisers to Use My Personal information
